The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Clinical trial NCT05841550 · RECRUITING

Trial details

NCT number: NCT05841550
Sponsor: Oslo University Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Smoldering Multiple Myeloma

Start date: 2023-05-19
Primary completion: 2027-05-19
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.